• 76600 Citations
  • 135 h-Index
1989 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2020

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

Hochhaus, A., Baccarani, M., Silver, R. T., Schiffer, C., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Deininger, M. W., Guilhot, F., Hjorth-Hansen, H., Hughes, T. P., Janssen, J. J. W. M., Kantarjian, H. M., Kim, D. W., Larson, R. A., Lipton, J. H., Mahon, F. X., Mayer, J., Nicolini, F. & 14 others, Niederwieser, D., Pane, F., Radich, J. P., Rea, D., Richter, J., Rosti, G., Rousselot, P., Saglio, G., Saußele, S., Soverini, S., Steegmann, J. L., Turkina, A., Zaritskey, A. & Hehlmann, R., Apr 1 2020, In : Leukemia. 34, 4, p. 966-984 19 p.

Research output: Contribution to journalReview article

Open Access
2 Scopus citations
2019

Hedgehog signaling inhibitors in solid and hematological cancers

Cortes, J. E., Gutzmer, R., Kieran, M. W. & Solomon, J. A., Jun 2019, In : Cancer Treatment Reviews. 76, p. 41-50 10 p.

Research output: Contribution to journalReview article

Open Access
8 Scopus citations

Improving attribution of adverse events in oncology clinical trials

George, G. C., Barata, P. C., Campbell, A., Chen, A., Cortes, J. E., Hyman, D. M., Jones, L., Karagiannis, T., Klaar, S., Le-Rademacher, J. G., LoRusso, P., Mandrekar, S. J., Merino, D. M., Minasian, L. M., Mitchell, S. A., Montez, S., O'Connor, D. J., Pettit, S., Silk, E., Sloan, J. A. & 6 others, Stewart, M., Takimoto, C. H., Wong, G. Y., Yap, T. A., Cleeland, C. S. & Hong, D. S., Jun 2019, In : Cancer Treatment Reviews. 76, p. 33-40 8 p.

Research output: Contribution to journalReview article

Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia

on behalf of the International CML Foundation Genomics Alliance, Aug 1 2019, In : Leukemia. 33, 8, p. 1835-1850 16 p.

Research output: Contribution to journalReview article

11 Scopus citations

Treatment-free remission with first- and second-generation tyrosine kinase inhibitors

Cortes, J., Rea, D. & Lipton, J. H., Mar 2019, In : American Journal of Hematology. 94, 3, p. 346-357 12 p.

Research output: Contribution to journalReview article

Open Access
28 Scopus citations
2018

Acute myeloid leukaemia

Short, N. J., Rytting, M. E. & Cortes, J. E., Aug 18 2018, In : The Lancet. 392, 10147, p. 593-606 14 p.

Research output: Contribution to journalReview article

66 Scopus citations

Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms

Mughal, T. I., Gotlib, J., Mesa, R., Koschmieder, S., Khoury, H. J., Cortes, J. E., Barbui, T., Hehlmann, R., Mauro, M., Saussele, S., Radich, J. P., Van Etten, R. A., Saglio, G., Verstovek, S., Gale, R. P. & Abdel-Wahab, O., Apr 2018, In : Leukemia Research. 67, p. 67-74 8 p.

Research output: Contribution to journalReview article

4 Scopus citations
2017

Frontline treatment of acute myeloid leukemia in adults

Tamamyan, G., Kadia, T., Ravandi, F., Borthakur, G., Cortes, J., Jabbour, E., Daver, N., Ohanian, M., Kantarjian, H. & Konopleva, M., Feb 1 2017, In : Critical Reviews in Oncology/Hematology. 110, p. 20-34 15 p.

Research output: Contribution to journalReview article

30 Scopus citations

Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management

Cortes, J. E., Jimenez, C. A., Mauro, M. J., Geyer, A., Pinilla-Ibarz, J. & Smith, B. D., Feb 1 2017, In : Clinical Lymphoma, Myeloma and Leukemia. 17, 2, p. 78-82 5 p.

Research output: Contribution to journalReview article

Open Access
17 Scopus citations

Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Bose, P., Vachhani, P. & Cortes, J. E., Mar 1 2017, In : Current treatment options in oncology. 18, 3, 17.

Research output: Contribution to journalReview article

65 Scopus citations
2016

Acute myeloid leukemia: advancing clinical trials and promising therapeutics

Daver, N., Cortes, J., Kantarjian, H. & Ravandi, F., May 3 2016, In : Expert Review of Hematology. 9, 5, p. 433-445 13 p.

Research output: Contribution to journalReview article

5 Scopus citations

Chronic myeloid leukemia: Reminiscences and dreams

Mughal, T. I., Radich, J. P., Deininger, M. W., Apperley, J. F., Hughes, T. P., Harrison, C. J., Gambacorti-Passerini, C., Saglio, G., Cortes, J. & Daley, G. Q., Apr 30 2016, In : Haematologica. 101, 5, p. 541-558 18 p.

Research output: Contribution to journalReview article

Open Access
31 Scopus citations

Omacetaxine Mepesuccinate for Chronic Myeloid Leukemia

Rosshandler, Y., Shen, A. Q., Cortes, J. & Khoury, H. J., May 3 2016, In : Expert Review of Hematology. 9, 5, p. 419-424 6 p.

Research output: Contribution to journalReview article

10 Scopus citations
2015

Diagnosis and Treatment of Chronic Myeloid Leukemia in 2015

Thompson, P. A., Kantarjian, H. M. & Cortes, J. E., Oct 2015, In : Mayo Clinic Proceedings. 90, 10, p. 1440-1454 15 p.

Research output: Contribution to journalReview article

Open Access
38 Scopus citations

Effectiveness of homoharringtonine (omacetaxine mepesuccinate) for treatment of acute myeloid leukemia: A meta-analysis of Chinese studies

Kantarjian, H., O'Brien, S., Jabbour, E., Barnes, G., Pathak, A. & Cortes, J., Jan 1 2015, In : Clinical Lymphoma, Myeloma and Leukemia. 15, 1, p. 13-21 9 p.

Research output: Contribution to journalReview article

10 Scopus citations

Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01

Ashizawa, A. T. & Cortes, J., Jul 1 2015, In : Expert Opinion on Drug Delivery. 12, 7, p. 1107-1120 14 p.

Research output: Contribution to journalReview article

17 Scopus citations

New treatment for acute myelogenous leukemia

DiNardo, C. D. & Cortes, J. E., Jan 1 2015, In : Expert Opinion on Pharmacotherapy. 16, 1, p. 95-106 12 p.

Research output: Contribution to journalReview article

21 Scopus citations

Progress in acute myeloid leukemia

Kadia, T. M., Ravandi, F., O'Brien, S., Cortes, J. & Kantarjian, H. M., Mar 1 2015, In : Clinical Lymphoma, Myeloma and Leukemia. 15, 3, p. 139-151 13 p.

Research output: Contribution to journalReview article

27 Scopus citations

Toward individualized therapy in acute myeloid leukemia a contemporary review

Kadia, T. M., Ravandi, F., Cortes, J. & Kantarjian, H., Sep 2015, In : JAMA Oncology. 1, 6, p. 820-828 9 p.

Research output: Contribution to journalReview article

Open Access
27 Scopus citations

Use of second- and third-generation tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia: An evolving treatment paradigm

Jabbour, E., Kantarjian, H. & Cortes, J., Jun 1 2015, In : Clinical Lymphoma, Myeloma and Leukemia. 15, 6, p. 323-334 12 p.

Research output: Contribution to journalReview article

72 Scopus citations
2014

Chronic myeloid leukemia in adolescents and young adults: Patient characteristics, outcomes and review of the literature

Pemmaraju, N. & Cortes, J., Apr 12 2014, In : Acta Haematologica. 132, 3-4, p. 298-306 9 p.

Research output: Contribution to journalReview article

11 Scopus citations

Investigational FMS-like tyrosine kinase 3 inhibitors in treatment of acute myeloid leukemia

Pemmaraju, N., Kantarjian, H., Andreeff, M., Cortes, J. & Ravandi, F., Jul 2014, In : Expert Opinion on Investigational Drugs. 23, 7, p. 943-954 12 p.

Research output: Contribution to journalReview article

20 Scopus citations

Omacetaxine: A protein translation inhibitor for treatment of chronic myelogenous leukemia

Gandhi, V., Plunkett, W. & Cortes, J. E., Apr 1 2014, In : Clinical Cancer Research. 20, 7, p. 1735-1740 6 p.

Research output: Contribution to journalReview article

Open Access
41 Scopus citations

Potential mechanisms of disease progression and management of advanced-phase chronic myeloid leukemia

Jabbour, E. J., Hughes, T. P., Cortés, J. E., Kantarjian, H. M. & Hochhaus, A., Jul 2014, In : Leukemia and Lymphoma. 55, 7, p. 1451-1462 12 p.

Research output: Contribution to journalReview article

22 Scopus citations

Practical issues surrounding the explosion of tyrosine kinase inhibitors for the management of chronic myeloid leukemia

Mathisen, M. S., Kantarjian, H. M., Cortes, J. & Jabbour, E. J., Sep 2014, In : Blood Reviews. 28, 5, p. 179-187 9 p.

Research output: Contribution to journalReview article

28 Scopus citations
2013

A journey searching for a cure for leukemia

Cortes, J. E., Jun 1 2013, In : Future Oncology. 9, 6, p. 785-787 3 p.

Research output: Contribution to journalReview article

Cardiovascular toxicity of tyrosine kinase inhibitors

Mouhayar, E., Durand, J. B. & Cortes, J., Sep 1 2013, In : Expert Opinion on Drug Safety. 12, 5, p. 687-696 10 p.

Research output: Contribution to journalReview article

16 Scopus citations

Chronic myeloid leukemia: Overview of new agents and comparative analysis

Jain, P., Kantarjian, H. & Cortes, J., Jun 1 2013, In : Current treatment options in oncology. 14, 2, p. 127-143 17 p.

Research output: Contribution to journalReview article

28 Scopus citations

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

Baccarani, M., Deininger, M. W., Rosti, G., Hochhaus, A., Soverini, S., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Guilhot, F., Hjorth-Hansen, H., Hughes, T. P., Kantarjian, H. M., Kim, D. W., Larson, R. A., Lipton, J. H., Mahon, F. X., Martinelli, G., Mayer, J., Müller, M. C. & 12 others, Niederwieser, D., Pane, F., Radich, J. P., Rousselot, P., Saglio, G., Saußele, S., Schiffer, C., Silver, R., Simonsson, B., Steegmann, J. L., Goldman, J. M. & Hehlmann, R., Aug 8 2013, In : Blood. 122, 6, p. 872-884 13 p.

Research output: Contribution to journalReview article

Open Access
1182 Scopus citations

Homoharringtonine/omacetaxine mepesuccinate: The long and winding road to food and drug administration approval

Kantarjian, H. M., O'Brien, S. & Cortes, J., Oct 1 2013, In : Clinical Lymphoma, Myeloma and Leukemia. 13, 5, p. 530-533 4 p.

Research output: Contribution to journalReview article

40 Scopus citations

Is acute myeloid leukemia a liquid tumor?

Ohanian, M., Faderl, S., Ravandi, F., Pemmaraju, N., Garcia-Manero, G., Cortes, J. & Estrov, Z., Aug 1 2013, In : International Journal of Cancer. 133, 3, p. 534-543 10 p.

Research output: Contribution to journalReview article

29 Scopus citations

Management of imatinib-resistant patients with chronic myeloid leukemia

Bhamidipati, P. K., Kantarjian, H., Cortes, J., Cornelison, A. M. & Jabbour, E., Apr 2013, In : Therapeutic Advances in Hematology. 4, 2, p. 103-117 15 p.

Research output: Contribution to journalReview article

Open Access
64 Scopus citations

Optimizing management of ruxolitinib in patients with myelofibrosis: The need for individualized dosing

Mesa, R. A. & Cortes, J., Oct 25 2013, In : Journal of Hematology and Oncology. 6, 1, 79.

Research output: Contribution to journalReview article

Open Access
32 Scopus citations

Phase II trials of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia

Ghanem, H., Kantarjian, H., Cortes, J., Quintás-Cardama, A. & Jabbour, E., Jan 1 2013, In : Expert Opinion on Orphan Drugs. 1, 8, p. 607-623 17 p.

Research output: Contribution to journalReview article

Re-emergence of interferon-α in the treatment of chronic myeloid leukemia

Talpaz, M., Hehlmann, R., Quintás-Cardama, A., Mercer, J. & Cortes, J., Apr 1 2013, In : Leukemia. 27, 4, p. 803-812 10 p.

Research output: Contribution to journalReview article

Open Access
88 Scopus citations

Resistance to tyrosine kinase inhibition therapy for chronic myelogenous leukemia: A clinical perspective and emerging treatment options

Jabbour, E. J., Cortes, J. E. & Kantarjian, H. M., Oct 1 2013, In : Clinical Lymphoma, Myeloma and Leukemia. 13, 5, p. 515-529 15 p.

Research output: Contribution to journalReview article

55 Scopus citations

Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009

Chen, Y., Wang, H., Kantarjian, H. & Cortes, J., Jul 1 2013, In : Leukemia and Lymphoma. 54, 7, p. 1411-1417 7 p.

Research output: Contribution to journalReview article

52 Scopus citations

Tyrosine kinase inhibition: A therapeutic target for the management of chronic-phase chronic myeloid leukemia

Jabbour, E. J., Cortes, J. E. & Kantarjian, H. M., Nov 29 2013, In : Expert Review of Anticancer Therapy. 13, 12, p. 1433-1452 20 p.

Research output: Contribution to journalReview article

15 Scopus citations
2012

Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy

Pemmaraju, N., Kantarjian, H., Shan, J., Jabbour, E., Quintas-Cardama, A., Verstovsek, S., Ravandi, F., Wierda, W., O'Brien, S. & Cortes, J., Jul 1 2012, In : Haematologica. 97, 7, p. 1029-1035 7 p.

Research output: Contribution to journalReview article

Open Access
48 Scopus citations

Bosutinib for the treatment of chronic myeloid leukemia in chronic phase

Quintás-Cardama, A., Kantarjian, H. & Cortes, J., Mar 1 2012, In : Drugs of Today. 48, 3, p. 177-188 12 p.

Research output: Contribution to journalReview article

5 Scopus citations

Current issues in chronic myeloid leukemia: Monitoring, resistance, and functional cure

Cortes, J., Goldman, J. M. & Hughes, T., Dec 21 2012, In : JNCCN Journal of the National Comprehensive Cancer Network. 10, SUPPL.3, p. S1-S13

Research output: Contribution to journalReview article

34 Scopus citations

Dasatinib for the treatment of Philadelphia chromosome-positive leukemias

Santos, F. P. S. & Cortes, J., Nov 1 2012, In : Expert Opinion on Pharmacotherapy. 13, 16, p. 2381-2395 15 p.

Research output: Contribution to journalReview article

7 Scopus citations

Hypocellular acute myeloid leukemia in adults: Analysis of the clinical outcome of 123 patients

Al-Kali, A., Konoplev, S., Lin, E., Kadia, T., Faderl, S., Ravandi, F., Ayoubi, M., Brandt, M., Cortes, J. E., Kantarjian, H. & Borthakur, G., Feb 1 2012, In : Haematologica. 97, 2, p. 235-240 6 p.

Research output: Contribution to journalReview article

Open Access
11 Scopus citations

Molecular resistance: An early indicator for treatment change?

Fava, C., Kantarjian, H. & Cortes, J., Apr 1 2012, In : Clinical Lymphoma, Myeloma and Leukemia. 12, 2, p. 79-87 9 p.

Research output: Contribution to journalReview article

6 Scopus citations

Molecular targeted therapy in acute myeloid leukemia

Daver, N. & Cortes, J., Apr 1 2012, In : Hematology. 17, SUPPL. 1, p. S59-S62

Research output: Contribution to journalReview article

25 Scopus citations

Treatment options for chronic myeloid leukemia

Tanaka, M. F., Kantarjian, H., Cortes, J., Ohanian, M. & Jabbour, E., Apr 1 2012, In : Expert Opinion on Pharmacotherapy. 13, 6, p. 815-828 14 p.

Research output: Contribution to journalReview article

12 Scopus citations

Tyrosine kinase inhibitors in acute and chronic leukemias

Ohanian, M., Cortes, J., Kantarjian, H. & Jabbour, E., May 1 2012, In : Expert Opinion on Pharmacotherapy. 13, 7, p. 927-938 12 p.

Research output: Contribution to journalReview article

44 Scopus citations
2011

Chronic Myeloid Leukemia: Mechanisms of Resistance and Treatment

Jabbour, E., Parikh, S. A., Kantarjian, H. & Cortes, J., Oct 1 2011, In : Hematology/Oncology Clinics of North America. 25, 5, p. 981-995 15 p.

Research output: Contribution to journalReview article

27 Scopus citations

Early cytogenetic and molecular response during first-line treatment of chronic myeloid leukemia in chronic phase: Long-term implications

Quintás-Cardama, A., Cortes, J. E. & Kantarjian, H. M., Dec 1 2011, In : Cancer. 117, 23, p. 5261-5270 10 p.

Research output: Contribution to journalReview article

14 Scopus citations

Emerging FMS-like tyrosine kinase 3 inhibitors for the treatment of acute myelogenous leukemia

Prescott, H., Kantarjian, H., Cortes, J. & Ravandi, F., Sep 1 2011, In : Expert Opinion on Emerging Drugs. 16, 3, p. 407-423 17 p.

Research output: Contribution to journalReview article

8 Scopus citations